{"id":"W2145434047","doi":"10.1016/s1470-2045(14)70417-6","title":"Abiraterone acetate for patients with metastatic castration-resistant prostate cancer progressing after chemotherapy: final analysis of a multicentre, open-label, early-access protocol trial","year":2014,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université de Montréal; McMaster University","funders":"Janssen Research and Development; National Cancer Institute","keywords":"Abiraterone acetate; Prostate cancer; Medicine; Oncology; Chemotherapy; Protocol (science); Internal medicine; Castration; Abiraterone; Cancer; Urology; Androgen deprivation therapy; Alternative medicine; Hormone; Pathology; Androgen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00802609,0.002918654,0.00331779,0.0004718522,0.000799928,0.002216588,0.001333295,0.001914435,0.008526463],"category_scores_gemma":[0.008967087,0.0009312783,0.003283105,0.0007690181,0.001783742,0.001641899,0.0009511496,0.004120774,0.001708765],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001615736,"about_ca_system_score_gemma":0.002962935,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002461237,"about_ca_topic_score_gemma":0.005588963,"domain_scores_codex":[0.9938154,0.004734511,0.000327972,0.0003989663,0.0003176005,0.0004055862],"domain_scores_gemma":[0.9952095,0.001809489,0.0011334,0.0007982083,0.0002789699,0.0007704957],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9874834,0.001524765,0.00053235,0.0004596511,0.001460034,0.00002153652,0.0000837796,0.0003226576,0.0006850897,0.0000834665,0.0007172161,0.006626046],"study_design_scores_gemma":[0.9806916,0.01554614,0.0018913,0.0000389773,0.000673319,0.00002423389,0.00002783126,0.0002129886,0.0001375592,0.0002334351,0.0005046116,0.0000180547],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9536738,0.004932929,0.003362726,0.001533367,0.0008062902,0.02386014,0.006936393,0.0003580765,0.004536384],"genre_scores_gemma":[0.9621831,0.00178898,0.004429607,0.001211133,0.0004026956,0.02166787,0.004033878,0.00008063656,0.004202167],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008526463,"threshold_uncertainty_score":0.04244655,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1270490815713082,"score_gpt":0.4639079775581205,"score_spread":0.3368588959868123,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}